Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 525.87% | 4.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 526.65% | 4.93% | |||
| Cost of Revenue | -47.36% | 313.53% | |||
| Gross Profit | 1,746.76% | -59.43% | |||
| SG&A Expenses | -30.15% | 16.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -57.38% | 129.41% | |||
| Operating Income | 149.81% | -182.43% | |||
| Income Before Tax | 137.61% | -140.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 137.61% | -140.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -4.55% | -9.59% | |||
| Net Income | 138.37% | -142.70% | |||
| EBIT | 149.81% | -182.43% | |||
| EBITDA | 153.37% | -195.38% | |||
| EPS Basic | 111.20% | 30.28% | |||
| Normalized Basic EPS | 112.63% | 32.65% | |||
| EPS Diluted | 111.20% | 30.28% | |||
| Normalized Diluted EPS | 112.63% | 32.65% | |||
| Average Basic Shares Outstanding | 240.69% | 250.46% | |||
| Average Diluted Shares Outstanding | 240.69% | 250.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||